Latest news
VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-G - BenzingaBenzinga · Thu, 06 Aug 2026 16:27:24 GMTVRXA Price Today: Veraxa Biotech AG Stock Price, Quote & Chart | MEXC - MEXCMEXC · Tue, 04 Aug 2026 18:49:42 GMTVRXA: Veraxa Biotech AG - Comparative Chart - Zacks Investment ResearchZacks Investment Research · Sun, 02 Aug 2026 23:35:47 GMTEnterprise value to revenue forward of Veraxa Biotech AG – NASDAQ:VRXA - TradingViewTradingView · Sat, 01 Aug 2026 04:35:00 GMTVeraxa Biotech Holding AG - Files To Register Resale Of Up To 25 Million Ordinary Shares - SEC Filing - TradingViewTradingView · Fri, 31 Jul 2026 21:19:46 GMTVeraxa Biotech (VRXA) grows patent estate for BiTAC cancer platforms - Stock TitanStock Titan · Fri, 31 Jul 2026 20:05:41 GMTVERAXA Biotech (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform - TradingViewTradingView · Thu, 30 Jul 2026 17:04:34 GMTVERAXA Biotech (VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT